Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews · Eyes and Vision

No studies found 1 · 14.3%GRADE not reported 0 · 0%Very low 6 · 85.7%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Pain during laser treatment ‐ not reported · proliferative diabetic retinopathy

It is very uncertain whether nd:YAG laser changes pain during laser treatment compared with argon‐green laser (very low certainty).

1 finding from 1 review

Different lasers and techniques for proliferative diabetic retinopathy 2018 · Cochrane Headline outcomes only
RR 1 [0.36, 2.76]
2 studies · 62 participants
Very low

BCVA: loss of 15 or more ETDRS letters · proliferative diabetic retinopathy

It is very uncertain whether nd:YAG laser changes BCVA: loss of 15 or more ETDRS letters compared with argon‐green laser (very low certainty).

1 finding from 1 review

Different lasers and techniques for proliferative diabetic retinopathy 2018 · Cochrane Headline outcomes only
RR 0.8 [0.3, 2.13]
1 study · 20 participants
Very low

BCVA: gain of 15 or more ETDRS letters · proliferative diabetic retinopathy

It is very uncertain whether nd:YAG laser changes BCVA: gain of 15 or more ETDRS letters compared with argon‐green laser (very low certainty).

1 finding from 1 review

Different lasers and techniques for proliferative diabetic retinopathy 2018 · Cochrane Headline outcomes only
RR 0.33 [0.02, 7.32]
1 study · 20 participants
Very low

Progression of PDR · proliferative diabetic retinopathy

It is very uncertain whether nd:YAG laser changes progression of PDR compared with argon‐green laser (very low certainty).

1 finding from 1 review

Different lasers and techniques for proliferative diabetic retinopathy 2018 · Cochrane Headline outcomes only
RR 1 [0.07, 14.95]
1 study · 42 participants
Very low

Regression of PDR · proliferative diabetic retinopathy

It is very uncertain whether nd:YAG laser changes regression of PDR compared with argon‐green laser (very low certainty).

1 finding from 1 review

Different lasers and techniques for proliferative diabetic retinopathy 2018 · Cochrane Headline outcomes only
RR 1 [0.87, 1.14]
1 study · 42 participants
Very low

Vision‐related QoL ‐ not reported · proliferative diabetic retinopathy

The review found no eligible studies for this question.

1 finding from 1 review

Different lasers and techniques for proliferative diabetic retinopathy 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Adverse events · proliferative diabetic retinopathy

It is very uncertain whether nd:YAG laser changes adverse events compared with argon‐green laser (very low certainty).

1 finding from 1 review

Different lasers and techniques for proliferative diabetic retinopathy 2018 · Cochrane Headline outcomes only
RR 1.22 [0.38, 3.94]
2 studies · 62 participants
Very low